Literature DB >> 15763783

Maternal and fetal outcome in eclamptic patients in Benin City, Nigeria.

S O Onuh1, A O Aisien.   

Abstract

Eclampsia is a well-recognised major cause of maternal death and perinatal morbidity and mortality. The incidence of eclampsia, its presentation patterns, maternal and perinatal outcomes were investigated in a retrospective study conducted at the University of Benin Teaching Hospital, Nigeria over an 8-year period, 1995 - 2002. There were 103 cases of eclampsia of 7835 deliveries, giving an incidence of one in 76 (1.32%). The mean age of the women was 27.1 +/- 5.6 years. Eclampsia significantly (P < 0.001) occurred in nulliparous and unbooked mothers. Eighty-nine (86.4%) of the patients developed fits in the predelivery stage; 85 (83%) of the patients had at least one premonitory symptom including headache (82.4%) visual disturbance (10.6%) and epigastric pain (7%). There were nine stillbirths and 16 early neonatal deaths for a perinatal mortality rate of 214/1000. The major causes of perinatal mortality were prematurity and birth asphyxia. Eleven maternal deaths occurred with a maternal case fatality rate of 10.7% and a maternal mortality ratio from eclampsia of 140/100 000. The clinical causes of deaths were cardiopulmonary failure, acute renal failure, haemolysis, elevated liver enzymes, low platelet count (HELLP) syndrome and cerebrovascular accident. Timely referral of high-risk patients coupled with availability of emergency obstetric and neonatal care services would reduce the incidence eclampsia associated mortality and morbidity in our facility.

Entities:  

Mesh:

Year:  2004        PMID: 15763783     DOI: 10.1080/01443610400009451

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  17 in total

1.  Ecalmpsia: maternal and fetal outcome.

Authors:  Tukur A Jido
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

Review 2.  Magnesium sulphate versus diazepam for eclampsia.

Authors:  Lelia Duley; David J Henderson-Smart; Godfrey Ja Walker; Doris Chou
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

Review 3.  Magnesium sulphate versus lytic cocktail for eclampsia.

Authors:  Lelia Duley; A Metin Gülmezoglu; Doris Chou
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

4.  Eclampsia and seasonal variation in the tropics - a study in Nigeria.

Authors:  Ugochukwu Vincent Okafor; Efenae Russ Efetie; Obasi Ekumankama
Journal:  Pan Afr Med J       Date:  2009-08-17

Review 5.  Public health perspectives of preeclampsia in developing countries: implication for health system strengthening.

Authors:  Kayode O Osungbade; Olusimbo K Ige
Journal:  J Pregnancy       Date:  2011-04-04

6.  Predictors of extra care among magnesium sulphate treated eclamptic patients at Muhimbili National Hospital, Tanzania.

Authors:  Projestine S Muganyizi; Mohammed S Shagdara
Journal:  BMC Pregnancy Childbirth       Date:  2011-06-03       Impact factor: 3.007

7.  Serum lipid profile and uric acid levels in preeclampsia in University of Benin Teaching Hospital.

Authors:  Nosakhare O Enaruna; Joseph O Idemudia; Paul I Aikoriogie
Journal:  Niger Med J       Date:  2014-09

8.  Maternal mortality predictors in women with hypertensive disorders of pregnancy: a retrospective cohort study.

Authors:  Yifru Berhan; Gezahegn Endeshaw
Journal:  Ethiop J Health Sci       Date:  2015-01

9.  Clinical features, current treatments and outcome of pregnant women with preeclampsaia/eclampsia in northern afghanistan.

Authors:  Sayed Shir Mohammad Ahadi; Yoshitoku Yoshida; Mirwais Rabi; Mohammad Abul Bashar Sarker; Joshua A Reyer; Nobuyuki Hamajima
Journal:  Nagoya J Med Sci       Date:  2015-02       Impact factor: 1.131

10.  Criteria-based audit on management of eclampsia patients at a tertiary hospital in Dar es Salaam, Tanzania.

Authors:  Hussein Lesio Kidanto; Ingrid Mogren; Siriel N Massawe; Gunilla Lindmark; Lennarth Nystrom
Journal:  BMC Pregnancy Childbirth       Date:  2009-03-27       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.